EU drugs agency finds AstraZeneca vaccine ‘safe and effective’

EYEAFRICA TV: Amsterdam, NETHERLANDS:- EU’s drug agency has said on Thursday that the use of the Oxford-AstraZeneca vaccine against COVID-19 is “safe and effective”.

“This is a safe and effective vaccine, its benefits in protecting people from COVID-19 with the associated risks of death and hospitalization outweigh the possible risks,” Emer Cooke, the European Medicine Agency (EMA) executive director, told a press conference in Amsterdam.

The EU regulator last week started an investigation to determine whether serious blood clots are side effects of AstraZeneca or instead a coincidence.

According to Cooke, the assessment of the Pharmacovigilance Risk Assessment Committee “concluded that the vaccine is not associated with an increase in the overall risk of thromboembolic events or blood clots.”

“When you vaccinate millions of people, it is inevitable that rare incidents happen,” she added.

However, the EMA’s head warned that a link between the reported cases and the vaccine cannot be ruled out definitively, so the agency will carry out further investigations and recommends raising awareness of possible risks.

Dr. Sabine Straus, chair of the investigation committee, also said they were unable to find any evidence of a “quality or batch issue.”

She also explained that there had been no increase in the overall risk of blood clots with the use of the AstraZeneca vaccine since the “number of thromboembolic events reported after vaccination is lower than the [number] expected in the general population.”

In total, 25 incidents were reported out of almost 20 million vaccinated people, said Straus.

Over the past week, several European countries – including Germany, France, Italy, Ireland, the Netherlands, Denmark, Sweden, and Norway – suspended the use of the AstraZeneca jab after serious or even fatal blood clots were reported in some vaccinated people.

The World Health Organization (WHO) on Thursday called on countries to continue using the vaccine, and is due to release the results of its own review into the vaccine’s safety on Friday.

The agency’s investigation focused on a small number of cases of unusual blood disorders. In particular, it was looking at cases of cerebral venous thrombosis – blood clots in the head.

0 0 vote
Article Rating


Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on telegram
Notify of
Inline Feedbacks
View all comments

Related Posts

Eye Africa TV
Would love your thoughts, please comment.x
Scroll to Top